Rubber Stopper Compatibility for Research Vials and Glassware

Rubber stopper compatibility has two separate meanings in a laboratory, and both must be satisfied. Mechanical compatibility is whether the stopper physically seats in the glassware aperture and holds a seal. Chemical compatibility is whether the elastomer, over the intended storage period, avoids adsorbing the contents, releasing extractable compounds into them or degrading under the sterilisation and handling applied. A stopper can pass the first test on the bench in seconds and still fail the second months later, so a defensible selection documents both.

This guide sets out how to size stoppers for glassware, how elastomer families differ, why biological safety certification does not establish compatibility, and how handling practice affects results. It is written for research laboratories, including those storing lyophilised peptides and reconstituted solutions in septum-sealed vials. All products referred to by Au Peptide Labs are for laboratory research use only, not for human or veterinary use.

Two questions: does it fit, and does it interact

The two questions are answered by different evidence.

Most search results for this topic address only the first row, with sizing charts. For laboratories handling peptides and other sensitive biological materials, the second row decides whether stored material remains within specification.

Sizing stoppers to glassware

Laboratory stoppers are tapered, so each size has a top (larger) and bottom (smaller) diameter, and the stopper seats correctly when the aperture falls between them. Reference descriptions of laboratory rubber stoppers give a Size #2 stopper as roughly 20 mm at the top, 16 mm at the bottom and 25 mm in height, suited to tubes of around 18 to 20 mm. Dimensions vary between manufacturers, so the vendor's own chart should always be the final reference.

A practical fitting procedure

1. Measure the inner diameter (ID) of the aperture with calipers, not a ruler. For test tubes and flasks the relevant dimension is the ID at the lip.
2. Select a stopper whose bottom diameter is smaller than the ID and whose top diameter is larger. Roughly one third to one half of the stopper's height should enter the neck.
3. Seat the stopper with a twisting motion. Do not use force, which risks cracking thin-walled glass.
4. Check the seal under the intended condition: inversion for liquids, reduced pressure for vacuum work, or a pressure hold for heated vessels.
5. Record the stopper size and material on the batch or experiment record so that the same configuration is reproducible.

Holes are a separate specification. Solid stoppers suit storage and closure, while one-hole or two-hole variants carry tubing or thermometers. A drilled stopper is a poor choice for long-term storage because the hole is a second seal interface.

Sizing is different for injection vials

Septum-sealed injection vials do not use tapered laboratory bungs. They use flanged closures, commonly described by the finish of the vial neck (for example, 13 mm or 20 mm), crimped with an aluminium seal. The vial and closure are specified as a system, and substituting a closure of the right nominal diameter but different formulation can change the seal and the chemistry. The vial-seal relationship is covered in more detail in our guide to vial seal integrity for peptides.

Elastomer families and what they suit

The base polymer governs permeability, resealability and the extractable profile. The following summary is general and should be confirmed against the specific compound data sheet.

Manufacturer literature, such as Aptar Pharma's description of its vial stoppers, positions bromobutyl for low extractables and leachables and for protecting lyophilised drugs from moisture, and chlorobutyl for non-buffered or acidic drugs. That is a supplier statement of intended use rather than a universal rule, which is why compatibility is verified per formulation.

Why biological safety does not equal compatibility

The most common error in stopper selection is treating a compliance statement as proof that the stopper suits a particular preparation. Compendial standards address defined questions. USP <381> sets biological, physicochemical and functionality requirements for elastomeric closures used with injectable products, and classifies them as Type I (for aqueous preparations, with the more stringent profile) or Type II (for uses such as non-aqueous preparations). Meeting these criteria shows that a closure is a suitable component in general terms. It does not demonstrate that it is compatible with a given peptide, buffer or excipient system.

The distinction matters for three reasons.

• Biological reactivity is not chemical interaction. A closure may be non-toxic in standard biological tests while still releasing compounds that alter a sensitive formulation, or binding the active component at its surface.
• Formulation variables change the outcome. pH, surfactants, organic co-solvents and ionic strength all alter what migrates from the elastomer. A compound that is stable in water may behave differently in a buffered, polysorbate-containing solution.
• Time is a factor. A closure must remain compatible through the entire intended storage period, not at the point of filling.

Extractables and leachables

Extractables are compounds that can be removed from the closure under exaggerated conditions, such as aggressive solvents or heat. Leachables are the compounds that actually migrate into the product under real storage. A Journal of Pharmaceutical Sciences paper on rubber-stoppered glass vial systems for biotechnology products describes a holistic E&L assessment for these systems, reflecting regulatory expectations for biologic product quality. Extractables studies identify what might appear; leachables studies, using the real product and conditions, confirm what does.

For laboratories that store peptides, a risk-based approach is proportionate:

1. Define the contact conditions: solvent or diluent, pH, additives, storage temperature, and intended duration.
2. Review the stopper manufacturer's extractables data and compare it with the formulation's sensitivities (for example, oxidation-prone residues or surfactant content).
3. Where the risk is material, run a small stability comparison of the product in the candidate stopper against an inert reference container, measuring purity and recovery over time.
4. Record the result and the exact closure specification used.

Our article on extractables and leachables for TGA dossiers develops the documentation side of this for Australian regulatory contexts.

Coated and laminated stoppers

Fluoropolymer film (ETFE or PTFE) on the product-contact face is used to reduce direct contact between the contents and the rubber. The same journal article and related literature treat such coatings as one way of lowering the risk of impurity migration into sensitive biological formulations. A coating is a risk-reduction measure, not a guarantee. The uncoated skirt, the needle-puncture path and the lyophilisation cycle can all still influence the result.

Adsorption, moisture and lyophilised material

Lyophilised peptides are hygroscopic, so water vapour ingress through or around the stopper is a quality concern in its own right. Low-permeability elastomers and a properly crimped seal limit this, and storage conditions then determine how much residual risk remains. The mechanisms are described in our guide to peptide hygroscopicity.

Adsorption is the opposite concern for dilute solutions. At low concentrations, a measurable fraction of peptide can be lost to surfaces, which appears as an unexplained fall in concentration rather than a visible fault. If recovery drops, compare the glass, closure and any transfer plastics before assuming the peptide has degraded.

Sterilisation and process changes

Compatibility established under one process does not automatically carry over to another. Steam autoclaving, gamma irradiation and dry heat each affect elastomers differently, and changes in stopper hardness, colour or extractable profile after a new sterilisation step are reasons to re-evaluate.

The same logic applies to supplier changes. If a supplier alters the rubber formulation, manufacturing process or sterilisation method, earlier compatibility conclusions may no longer hold. Good practice is to:

• obtain written confirmation from the supplier that the composition matches the lot used in your original work;
• request notification of changes to formulation or process;
• retain the lot number of the closure alongside experimental records;
• repeat a reduced compatibility check when any of these change.

USP <381> places the responsibility for demonstrating continued suitability with the party that uses the closure in the final system, not with the stopper maker alone.

Handling: the outer surface is not sterile

Contamination introduced during handling is frequently misread as a stopper fault. A stopper is designed to protect the contents through its shelf life, but its outer surface is not required to be sterile. A TGA safety alert on propofol emulsion is the Australian regulator's reference point for the practice of wiping the stopper with an appropriate disinfectant such as 70% alcohol and allowing it to dry completely before a needle is inserted.

In a research setting, the same controls apply:

1. Remove the flip-off cap only at the point of use, inside the clean work zone.
2. Wipe the stopper with a 70% alcohol swab and let it evaporate fully. Alcohol carried into the vial on the needle is a separate contamination of the sample.
3. Use a fresh sterile needle for each puncture and avoid coring by inserting at a consistent angle, bevel up.
4. Limit the number of punctures per stopper and discard the vial if the septum shows visible damage.
5. Record puncture count and storage temperature between uses.

The diluent also has a bearing on how long a punctured vial can be held. The choice between bacteriostatic and sterile water is addressed in bacteriostatic vs sterile water, and bench technique is covered in the aseptic handling guide.

Our perspective

At Au Peptide Labs, the closure is treated as part of the product rather than as packaging that sits beside it. Our position is that a purity figure only has meaning if the container preserves it, so a certificate of analysis (COA) for a batch and the condition of the closure on arrival belong in the same inspection. We supply research peptides with independent third-party purity testing above 99% and verifiable COAs for every batch, and we recommend that receiving laboratories verify the closure at the same time as the contents.

In practice we advise researchers to do three things. First, inspect the stopper and crimp on receipt for displacement, cracks, or residue, using the criteria in our visual inspection guidance. Second, treat any stopper substitution, for example when transferring material to a different vial, as a change that requires its own compatibility check rather than a like-for-like swap. Third, keep the E&L reasoning proportionate: a short-term reconstituted aliquot has a different risk profile from material held for months. Because we dispatch from Melbourne within one business day, with no customs delay, material reaches Australian laboratories with less time in transit, which limits one variable, though it does not replace verification on receipt.

— Dr. Authur

Research supplies from Au Peptide Labs

Laboratories that need peptides together with the consumables used to handle them can order both from one Australian source. Our Lab Supplies range covers items such as insulin syringes, alcohol wipes and bacteriostatic water, and the peptide categories, including Recovery & Repair, are stocked and shipped within Australia. Express Post is listed at $10 as a one-off fee. Custom and bulk orders are available on request through the Au Peptide Labs store. All products are for laboratory research use only.

A selection checklist

• Confirm the closure type: tapered bung for general glassware, flanged closure for septum vials.
• Measure the aperture and match it to the supplier's chart.
• Identify the elastomer and any coating, and match it to the formulation's pH, solvents and additives.
• Obtain extractables data and decide whether a formulation-specific E&L study is warranted.
• Confirm the sterilisation method and that it matches what was tested.
• Obtain written confirmation of unchanged composition from the supplier.
• Define wiping, puncture and storage rules for the stopper in use.
• Record lot numbers and closure specification for each experiment.

Further receipt-stage checks are listed in our note on peptide quality standards.

Frequently asked questions

What does a rubber stopper do in a laboratory?

A rubber stopper closes the aperture of a flask, tube or vial to contain the contents, limit evaporation and exclude contaminants. In injection vials the stopper also provides a septum that can be pierced by a needle and then reseal. Its performance depends on the material, the fit and the integrity of the crimp seal.

How do I size a rubber stopper?

Measure the inner diameter of the glassware opening and select a stopper whose bottom diameter is smaller and top diameter larger than that measurement. Check the supplier's size chart, because the numbering and dimensions differ between manufacturers. Confirm the seal under the conditions of use.

Does USP Class VI or USP <381> compliance guarantee compatibility with my peptide?

No. These standards address biological safety and general closure requirements, not interaction with a specific formulation. Compatibility depends on factors such as pH, surfactants and storage time, and is assessed through risk-based extractables and leachables work and stability data.

Is the outside of a vial stopper sterile?

No. The outer surface is not required to be sterile, so it should be wiped with 70% alcohol and allowed to dry before each needle insertion. This applies regardless of the stopper material.

Sources

• USP <381> Elastomeric Closures for Injections
• A Holistic Approach of Extractables and Leachables Assessment of Rubber Stoppered Glass Vial Systems, Journal of Pharmaceutical Sciences
• Laboratory rubber stopper, Wikipedia
• Revised Ph. Eur. Chapter 3.2.9 Rubber Closures, ECA Academy
• Vial containment solutions: stoppers for liquid and lyophilised drugs, Aptar Pharma
• TGA safety alert: propofol emulsion for injection, update 3

Recommended

• 12 Steps for Safe Vacuum Desiccator Use for Researchers and Technicians
• Prevent Disconnections: Luer Lock vs Slip Tip for Clinics and Labs
• Stop Losing 0.2–5 µL: Bench Workflow for Small Volume Pipetting